What amount sold does SIWA RMI Company, LLC report in Form D filings?

The latest linked filings report $200K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was SIWA RMI Company, LLC's most recent SEC filing?

SIWA RMI Company, LLC's most recent Form D filing was on 2015-11-12.

How many investors does SIWA RMI Company, LLC have?

The most recent Form D filing lists 5 investor(s).

What type of securities does SIWA RMI Company, LLC offer?

SIWA RMI Company, LLC's SEC Form D filings indicate equity offerings.

SIWA RMI Company, LLC

CIK: 0001655607·Biotechnology·CHICAGO, IL·Limited Liability Company·Founded 2012

Reported Sold

$200,000

Total Filings

Identified Offerings

Last Filed

Nov 12, 2015

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Nov 12, 2015Form D — New notice

Reported sold: $200,000 · Target: $500,000

Rule 506(b)·5 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

$1 - $1,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$200,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Misty Sue Gruber

Related Person

Appears on 1 filing

Lewis Steven Gruber

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 12, 2015	New	$500,000	$200,000	5

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Neopenda, PBC

Biotechnology

Offering target: $500,000

Filed Aug 27, 2026